Clinuvel Pharmaceuticals Quote - CUV

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

11.84

Bid

11.73

Offer

12.00

Volume

121,073

11.715 Day's Range 12.00

11.715 52 Week Range 17.71

Market Cap

593.229M

Previous Close

11.95

Open

12.00

Last Trade

198

11.79

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

96,760

Shares Outstanding

50,103,765

Dividend Yield

PE Ratio

16.65

Earnings Per Share (EPS)

0.71

Revenue

88.74M

Net Profit

35.64M

Sector

Medicinal Chems,botanicl Pds

Industry

Drugs-health R&d/testing Labs

Website

www.clinuvel.com

Headquarters

Melbourne, Victoria, Aus

Founded

2000

Clinuvel Pharmaceuticals Limited is listed in the Medicinal Chems,botanicl Pds sector of the Australian Stock Exchange with ticker CUV. The last closing price for Clinuvel Pharmaceuticals was AUD11.95. Over the last year, Clinuvel Pharmaceuticals shares have traded in a share price range of AUD 11.715 to AUD 17.71.

Clinuvel Pharmaceuticals currently has 50,103,765 shares in issue. The market capitalisation of Clinuvel Pharmaceuticals is AUD598.74 million. Clinuvel Pharmaceuticals has a price to earnings ratio (PE ratio) of 16.65.

Europe Approves Novel Australian Drug Developed for Rare Sun Disease

The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA...

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study

Clinical Significance and Benefit from SCENESSE(R) in US Phase III EPP study Primary endpoint shows a strong statistical trend in pain-free exposure following the treatment of the 'orphan...

Clinuvel Files European Marketing Authorisation Application for SCENESSE® (afamelanotide)

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) today announced that it has submitted a marketing authorisation application (MAA) for its first-in-class...

Clinuvel announces positive results of first Phase II US study of SCENESSE® in orphan disease erythropoietic protoporphyria ...

Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY), a global biopharmaceutical company with unique expertise on the interaction of light and human skin...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.81	-6.40316205534	12.65	12.84	11.715	141473	12.17207456	DE
4	-1.65	-12.2312824314	13.49	13.79	11.715	124723	12.69879916	DE
12	-2.66	-18.3448275862	14.5	14.96	11.715	96760	13.44997364	DE
26	-3.15	-21.0140093396	14.99	17.71	11.715	90109	14.2065527	DE
52	-3.96	-25.0632911392	15.8	17.71	11.715	95618	14.59178175	DE
156	-15.1	-56.0504825538	26.94	29.39	11.715	100664	17.70313699	DE
260	-17.62	-59.8099117447	29.46	44.67	11.715	123185	21.63476685	DE

CUV - Frequently Asked Questions (FAQ)

What is the current Clinuvel Pharmaceuticals share price?

The current share price of Clinuvel Pharmaceuticals is AUD 11.84

How many Clinuvel Pharmaceuticals shares are in issue?

Clinuvel Pharmaceuticals has 50,103,765 shares in issue

What is the market cap of Clinuvel Pharmaceuticals?

The market capitalisation of Clinuvel Pharmaceuticals is AUD 598.74M

What is the 1 year trading range for Clinuvel Pharmaceuticals share price?

Clinuvel Pharmaceuticals has traded in the range of AUD 11.715 to AUD 17.71 during the past year

What is the PE ratio of Clinuvel Pharmaceuticals?

The price to earnings ratio of Clinuvel Pharmaceuticals is 16.65

What is the cash to sales ratio of Clinuvel Pharmaceuticals?

The cash to sales ratio of Clinuvel Pharmaceuticals is 6.69

What is the reporting currency for Clinuvel Pharmaceuticals?

Clinuvel Pharmaceuticals reports financial results in AUD

What is the latest annual turnover for Clinuvel Pharmaceuticals?

The latest annual turnover of Clinuvel Pharmaceuticals is AUD 88.74M

What is the latest annual profit for Clinuvel Pharmaceuticals?

The latest annual profit of Clinuvel Pharmaceuticals is AUD 35.64M

What is the registered address of Clinuvel Pharmaceuticals?

The registered address for Clinuvel Pharmaceuticals is LEVEL 11, 535 BOURKE STREET, MELBOURNE, VICTORIA, 3000

What is the Clinuvel Pharmaceuticals website address?

The website address for Clinuvel Pharmaceuticals is www.clinuvel.com

Which industry sector does Clinuvel Pharmaceuticals operate in?

Clinuvel Pharmaceuticals operates in the DRUGS-HEALTH R&D/TESTING LABS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ODEOOdessa Minerals Ltd	AUD 0.002 (100.00%)	500k
LM1Leeuwin Metals Ltd	AUD 0.10 (66.67%)	468.95k
RADORadiopharm Theranostics Ltd	AUD 0.008 (60.00%)	200k
PKOPeako Limited	AUD 0.003 (50.00%)	166.67k
ENVOEnova Mining Ltd	AUD 0.003 (50.00%)	250k
JAYJayride Group Limited	AUD 0.003 (-40.00%)	5.13M
CZNCorazon Mining Ltd	AUD 0.002 (-33.33%)	7.71M
1AIOAlgorae Pharmaceuticals Ltd	AUD 0.002 (-33.33%)	1.55M
GTRGTI Energy Ltd	AUD 0.003 (-25.00%)	5.68M
TTITraffic Technologies Ltd	AUD 0.003 (-25.00%)	4.6M
VAUVault Minerals Ltd	AUD 0.325 (-1.52%)	52.89M
EVNEvolution Mining Ltd	AUD 4.80 (0.00%)	38.65M
RSGResolute Mining Limited	AUD 0.4025 (0.63%)	37.61M
SYASayona Mining Limited	AUD 0.0255 (4.08%)	36.86M
MSBMesoblast Limited	AUD 2.40 (-21.31%)	34.45M